HengRui USA

Our work here at HengRui USA focuses on the multiple stages of the drug development process, from both a clinical and regulatory perspective. HengRui USA operates as the U.S. hub for our parent company’s Drug Development network by providing local expertise and resources for both U.S. and global development initiatives of Jiangsu Hengrui Pharmaceuticals.

Learn more

Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals is a global pharmaceutical company engaged in the research, development, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, surgical drugs, contrast agents and antibiotics. The company was established in 1970 and is headquartered in Lianyungang, Jiangsu. It was listed on the Shanghai Stock Exchange in 2000. It is also the largest listed pharmaceutical company in China. As of the end of 2019, it has more than 24,400 employees worldwide.